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Objective: To explore the hypoglycaemic and hypocholesterolemic potential of con-
ventional and supercritical extracts of black cumin.
Methods: Purposely, rat modelling was carried out for 2 months by designing three
studies i.e. study I (normal rats), study II (hyperglycaemic rats) and study III (hyper-
cholesterolemic rats). Each study was further divided into three groups based on diet i.e.
control, functional diet (contained extract of black cumin prepared by using conventional
solvent) and nutraceutical diet (contained extract of black cumin prepared by supercritical
ﬂuid extraction system).
Results: During whole trial, an abating trend was observed in the level of serum
cholesterol with maximum reduction (12.8%) in nutraceutical group of study III. Low
density lipoprotein and triglyceride level was also lowered maximum in study III as
17.1% and 11.6%, respectively. Whereas, highest decline in glucose level was in nu-
traceutical group of study II as 11.2%.
Conclusions: Inclusion of black cumin extracts in diet signiﬁcantly lowers the occur-
rence of hyperglycaemia and hypercholesterolaemia. Furthermore, hypoglycaemic and
hypocholesterolemic potential of nutraceutical diet is more prominent as compared to
functional diet.1. Introduction
Poor dietary habits, changing lifestyles and escalating con-
sumption of processed food have paved the way towards
various physiological dysfunctions. Metabolic disorders likehyperglycaemia and hypercholesterolaemia have become a great
threat for sustaining healthy human life. Prevention of these
malfunctions has become a major public health concern world-
wide especially in developing nations. Thus, researchers are
converging their attention for the identiﬁcation of natural rem-
edies to handle metabolic syndromes. For the purpose, numerous
phytochemicals have been isolated from food items especially
herbs and spices. These phytochemicals are widely used in the
intervention and prevention of numerous disorders owing to
their therapeutic potential and high pharmacological safety [1].
Diet based therapy with special reference to polyphenols has
been invigorated worldwide and people are using natural food
materials as an intervention against various maladies. In the past
few decades, several attempts have been carried out to explore
the pharmacological characteristics of a delicate and attractive
spicy herb known by scientiﬁc name Nigella sativa (N. sativa)
Linnaeus which belongs to the family Ranunculaceae [2]. It is
also known as black cumin or black seed [3]. For thousands ofs article under the CC BY-NC-ND license (http://
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numerous foods like bread, pickles and other products [4].
Black cumin is rich in oil, proteins, minerals and
carbohydrates [5]. Fixed and essential oils of black cumin are
rich in active ingredients having health promoting potential [6].
Furthermore, studies showed that most of the fat contents are
in the form of U-3 and U-6 fatty acids [7]. The oil of black
cumin is enriched with unsaturated fatty acids, terpenoids and
various kinds of quinones like thymoquinone, along with
some alkaloids in lesser quantities. Collectively these all are
good for enhancing memory [8]. Along with balanced fatty
acid composition, it also contains various bioactive
components and tocopherols. Most of the biological activity
has been attributed to the major constitutes of the essential oil:
thymoquinone (24.5%–57.0%), r-cymene (10.7%–40.3%) and
a-thujen (1.9%–8.2%) [9,10].
Black cumin seeds contain considerable amounts of alkaloids
like nigellicine, nigellidine and nigellimine, which are reported as
cholesterol lowering agents [11]. Thymoquinone is effective
against cancer, oxidative stress, diabetic complications and
immune dysfunction as explored by several pharmacological
investigations. Moreover, it has a major role in the regulation
and maintenance of body homeostasis and hypocholesterolemic
effect [8,12].
In recent years, black cumin is in limelight as an anti-diabetic
drug owing to its ability to maintain integrity of b-cells. Diabetes
mellitus is one of the leading causes of mortality all over the globe
and if uncontrolled, it can target at multi-organ systems. It was
observed that most diabetic cases are type II, while type I diabetes
occur in childhood. According to the estimates, 376 million people
worldwide in 2030will be affectedwith diabetes [13]. Furthermore,
studies have shown that dyslipidaemia is a major cause for
cardiovascular diseases which ultimately results in high rates of
morbidity and mortality among people all over the world [14]. It
has been explored in various research investigations that
maintained level of plasma cholesterol is important for protection
from cardiovascular disease, as hypercholesterolaemia plays a
vital role in the occurring of atherosclerosis [15]. Protection from
cardiovascular disease is also important in a community when
people are already suffering from other chronic diseases like
diabetic mellitus and cancer [16].
The vegetable oil is conventionally extracted by mechanical
cold-pressing process or using a solvent. Conventional methods
such as solvent extraction and soxhlet, although effective for
extraction, can lead to degradation of heat sensitive compounds
as well as leave traces of toxic solvents in the solute [17]. This is
a concern for food and pharmacy industry, because of the
increasing regulation of harmful solvents used [18]. On the
other hand, supercritical ﬂuid extraction is one of the most
promising techniques that attract the interest of process
engineers. With supercritical ﬂuid extraction, higher yields and
better-quality products can be achieved. Although this process
requires high pressures, there is no risk of ﬁre or toxicity; solvent
removal is simple, efﬁcient and storage capability of extract can
be extended. Moreover, process residue has certain nutritional
value and can be used to feed cattle [19].
The objective of this research was to explore and compare the
hypoglycaemic as well as hypocholesterolemic potential of
conventional and supercritical ﬂuid extracts of black cumin. This
would help in more efﬁcient recovery of bioactive moieties from
black cumin along with carving the way for the development of
functional foods.2. Materials and methods
2.1. Procure of materials and preparation of powder
The present study was conducted in the Functional and Nu-
traceutical Food Research Section, National Institute of Food
Science and Technology, University of Agriculture, Faisalabad.
Black cumin of indigenous variety was procured from local su-
permarket considering the quality attributes like uniformity in
shape, colour and size followed by cleaning. For bioevaluation,
Sprague Dawley rats were housed in the animal room of National
Institute of Food Science and Technology. Diagnostic kits were
purchased from Sigma–Aldrich, Bioassay (Bioassays Chemical
Co. Germany) andCaymanChemicals (Cayman Europe, Estonia).
Cleaned black cumin was ground to a ﬁne powder using grinding.
Resultant black cumin powder was stored in air tight plastic bags
for extraction of bioactive moieties and bioefﬁcacy trial.
2.2. Preparation of black cumin extracts
2.2.1. Conventional solvent extraction
The conventional solvent extract was prepared by using
aqueous methanol (50% v/v) selected based on preliminary tri-
als. For the purpose, powdered black cumin was taken in a
conical ﬂask and solvent was added in ratio of 1:6 (black cumin
powder: solvent). Afterwards, the mixture was shaked in orbital
shaker at 180 rpm at 50 C temperature for 50 min. Finally,
extract was ﬁltered and subjected to rotary evaporator (Eyela,
Japan) for removal of surplus solvent [20].
2.2.2. Supercritical ﬂuid extraction
Supercritical black cumin extract was obtained by using su-
percritical ﬂuid extractor (SC-CO2), model SFT-150 (supercrit-
ical ﬂuid extractor incorporation USA) at 7500 psi pressure and
40 C temperature for 180 min [21]. The solvent and extracting
conditions in both conventional and supercritical ﬂuid
extractions were selected based on preliminary trials and
antioxidant proﬁling of different solvents.
2.3. Ethical approval
Ethics approval was given by the head of the National
Institute of Food Science and Technology, University of Agri-
culture Faisalabad, Pakistan; by reviewing the suggestions of
Animal Experimentation Ethics Committee, University of
Agriculture Faisalabad. Animal experiments were conducted
accordance with the instructions for the care and use provided by
the committee and instructed by the university.
2.4. Animal feed modelling
Ninety Sprague Dawley rats were housed in animal room of
National Institute of Food Science and Technology, University
of Agriculture, Faisalabad, Pakistan. Initially, some rats were
sacriﬁced to establish baseline trend. The study was carried out
in three categories separately. Study I comprised of rats fed on
normal diet, whereas in study II and III, high sucrose and high
cholesterol diets (Table 1) were given to induce hyperglycaemia
and hypercholesterolaemia in them, respectively.
Efﬁcacy study was further divided into three segments i.e.
normal, hyperglycaemic and hypercholesterolemic rats. Three
Table 1
Composition of diets given to trial animals.
Ingredients (%) Normal diet High sucrose diet High cholesterol diet
Corn oil 10 10 10.0
Corn starch 66 26 64.5
Casein 10 10 10.0
Cellulose 10 10 10.0
Salt mixture 3 3 3.0
Vitamins 1 1 1.0
Cholesterol – – 1.5
Sucrose – 40 –
Figure 1. Feed intake of rats increased in all studies from 1st week to 8th
week.
a) normal rats, b) hyperglycaemic rats, c) hypercholesterolemic rats.
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and nutraceutical diets.
During entire experimental period of two months, the animal
room was maintained at a temperature and relative humidity of
(23 ± 2) C and 55% ± 5% respectively, with 12:12 h light: dark
cycle (NIH Publications No. 8023, revised 1978). The rodent
diet prepared by the incorporation of conventional extracts and
supercritical extracts was accordingly labelled as functional and
nutraceutical diet. During trial, normal, functional and nutra-
ceutical diets were given to the respective groups under each
study to evaluate the effects of individual treatment on the
selected parameters including serum lipid proﬁle, glucose and
insulin levels.
2.5. Indexes observation
2.5.1. Feed, drink intakes and body weight gain
Average feed and water intake of each group were measured
on daily basis during the whole study period [22]. Increase in
body weight of rats from all experimental groups was
measured weekly throughout the study period.
2.5.2. Serum lipid proﬁle
The blood was collected by direct cardiac puncture and sera
were obtained by centrifugation at 5000 rpm for 5 min at 4 C.
Serum lipid proﬁle of rats was measured by following their
respective protocols. Serum cholesterol level of rats was
measured using CHOD–PAP method following the protocol of
Kim et al. [23]. High density lipoprotein (HDL) and low density
lipoproteins (LDL) in serum samples were calculated by method
as mentioned by Suleria et al. [24]. Triglycerides in serum
sample were estimated by liquid triglycerides method as
illustrated by Buriro and Tayyab [25].
2.5.3. Serum glucose and insulin levels
For each study, the collected sera were evaluated for glucose
concentration by GOD–PAP method as described by Kim et al.
[22], whereas insulin level was assessed by following the method
of Ahn et al. [26].
2.6. Statistical analysis
Data obtained were statistically analysed by employing
ANOVA to check the level of signiﬁcance followed by mean
comparisons by Tukey's honest signiﬁcant difference test [27].
3. Results
3.1. Feed intake, drink intake and body weight
It was noticed that treatments imparted non-signiﬁcant effect
on feed intake in all three studies. However, time interval
effected signiﬁcantly the feed intake of all studies. During two-
month trial, feed intake in control group, functional and nutra-
ceutical groups has increased from (13.5 ± 0.4) to (19.4 ± 0.9) g/
rat/day, (13.3 ± 0.4) to (19.1 ± 0.8) g/rat/day and (12.7 ± 0.3) to
(18.9 ± 0.8) g/rat/day, respectively, in study I. Similarly, in study
II (hyperglycaemic rats) maximum feed intake was increased in
control group from 1st to 8th week [(14.4 ± 0.6)-(21.2 ± 1.0) g/
day/rat] followed by functional and nutraceutical group,
[(14.1 ± 0.6)-(21.0 ± 1.1) g/day/rat and (13.9 ± 0.4)-(20.7 ± 0.9)
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olemic rats) maximum increase in feed intake was observed in
control group from (13.9 ± 0.5) to (20.7 ± 0.9) g/rat/day, while,
functional and nutraceutical group also showed increase in feed
intake from (13.5 ± 0.7) to (20.6 ± 0.9) g/rat/day and
(12.8 ± 0.3) to (19.8 ± 0.8) g/rat/day, respectively, throughout
the study period (Figure 1).
In case of water intake, it was noticed that treatment had non-
substantial effect while intervals had momentous effect on water
intake in all study groups. In study I, water intake in control
group, functional and nutraceutical groups have increased fromFigure 2. Drink intake of rats increased in all studies from 1st week to 8th
week.
a) normal rats, b) hyperglycaemic rats, c) hypercholesterolemic rats.(19.6 ± 0.8) to (24.0 ± 1.2) mL/rat/day, (18.5 ± 0.7) to
(23.7 ± 1.1) mL/rat/day and (18.3 ± 0.9) to (23.1 ± 1.0) mL/rat/
day, correspondingly, during whole trial. Furthermore, in study
II the water intake increased throughout the study tenure in
control, functional and nutraceutical groups from (20.0 ± 0.9) to
(25.1 ± 1.2) mL/rat/day, (19.9 ± 0.9) to (24.3 ± 1.2) mL/rat/day
and (18.9 ± 0.9) to (23.9 ± 1.1) mL/rat/day, respectively.
Likewise, in hypercholesterolemic rats the maximum increase
was observed in nutraceutical group followed by functional and
control group as (18.5 ± 0.8) to (23.5 ± 1.2) mL/rat/day,Figure 3. Body weight of rats increased in all studies over the period of 8
weeks.
a) normal rats, b) hyperglycaemic rats, c) hypercholesterolemic rats.
Table 3
HDL (mg/dL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 35.2 ± 1.5 35.3 ± 1.4 35.5 ± 1.0
Functional 35.8 ± 1.5 36.2 ± 1.9 36.5 ± 1.1
Nutraceutical 36.6 ± 1.7 37.0 ± 1.8 37.4 ± 1.3
Study II Control 39.4 ± 1.4 38.9 ± 1.5 38.6 ± 1.6
Functional 39.6 ± 1.4 40.1 ± 1.6 40.6 ± 1.7
Nutraceutical 40.2 ± 1.5 40.8 ± 1.6 41.3 ± 1.8
Study III Control 55.6 ± 2.0 54.8 ± 2.0 54.3 ± 2.1
Functional 53.7 ± 2.0 54.6 ± 2.1 55.2 ± 2.0
Nutraceutical 54.5 ± 2.4 55.5 ± 2.3 56.2 ± 1.8
Study I (normal rats), study II (hyperglycaemic rats), study III (hyper-
cholesterolemic rats).
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(24.8 ± 1.3) mL/rat/day, respectively (Figure 2).
In case of body weight treatments and interval imparts sig-
niﬁcant effect on body weight in all studies. In normal group of
rats (study I), maximum body weight was observed in control
diet group [(183.3 ± 7.6) g/rat/week] followed by functional
[(179.2 ± 6.2) g/rat/week] and nutraceutical [(177.7 ± 6.5) g/rat/
week] groups. The body weight for control, functional and nu-
traceutical groups was increased from (137.8 ± 5.2) to
(227.4 ± 8.2) g/rat/week, (135.9 ± 5.5) to (221.8 ± 8.1) g/rat/
week and (134.4 ± 6.2) to (224.2 ± 9.5) g/rat/week, respectively,
throughout the study trial. Likewise, in hyperglycaemic group of
rats (study II) the highest body weight was observed in control
group [(192.6 ± 6.6) g/rat/week] followed by functional
[(187.8 ± 7.9) g/rat/week] and nutraceutical [(181.2 ± 8.9) g/rat/
week] group. Similarly, in case of hypercholesterolemic rats
(study III) highest body weight was noticed in control group
[(199.8 ± 8.6) g/rat/week]; however, minimum in nutraceutical
[(190.4 ± 8.8) g/rat/week] group. In both study II and III the
body weight of all groups showed a signiﬁcant weight gain
during study period (Figure 3).
3.2. Hypocholesterolemic potential
3.2.1. Cholesterol
In study I, mean serum cholesterol level was affected
signiﬁcantly by treatments and maximum level was observed in
control [(83.0 ± 4.0) mg/dL] followed by functional
[(77.8 ± 3.9) mg/dL] and nutraceutical [(75.9 ± 3.4) mg/dL]
groups at 60 d (Table 2). In studyI, reduction in serum choles-
terol level was 4.4% and 5.3% in rat groups fed on functional
and nutraceutical, respectively. Likewise, in hyperglycaemic
study group (study II), maximum reduction in serum cholesterol
level was observed in nutraceutical group (9.1%) followed by
functional group (7.5%). The serum cholesterol level in control
group has increased while a decreasing trend observed in
functional and nutraceutical groups during the trial period.
In study III (hypercholesterolemic rats), maximum mean
serum cholesterol level was observed in control group trailed by
functional and nutraceutical group. During the sixty days trial
maximum reduction was assessed in nutraceutical group from
(145.7 ± 6.3) to (127.0 ± 5.0) mg/dL followed by functionalTable 2
Cholesterol (mg/dL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 81.9 ± 4.3 82.6 ± 4.6 83.0 ± 4.0
Functional 81.4 ± 4.0 79.3 ± 4.0 77.8 ± 3.9*
Nutraceutical 80.2 ± 4.1 77.8 ± 3.5 75.9 ± 3.4*
Study II Control 98.0 ± 4.5 99.9 ± 4.3 101.2 ± 4.8
Functional 97.6 ± 4.9 93.4 ± 4.1 90.2 ± 4.1*
Nutraceutical 97.3 ± 4.3 92.2 ± 3.9 88.4 ± 4.0**
Study III Control 144.4 ± 6.4 151.7 ± 6.9 157.1 ± 7.2*
Functional 146.2 ± 6.5 136.8 ± 5.7 130.5 ± 6.2**
Nutraceutical 145.7 ± 6.3 135.1 ± 6.8 127.0 ± 5.0***
Study I (normal rats), study II (hyperglycaemic rats), study III (hyper-
cholesterolemic rats). Asterisks indicate that the differences (*: P < 0.05;
**: P < 0.01; ***: P < 0.001) between the means of different diets
(control, functional and nutraceutical) are statistically signiﬁcant as
determined by one-way ANOVA with posthoc Tukey's honestly sig-
niﬁcant difference test.(146.2 ± 6.5) to (130.5 ± 6.2) mg/dL. Maximum decline in
serum cholesterol level was in groups fed on nutraceutical
(12.8%) followed by functional (10.7%).
3.2.2. HDL
In study I, the group of rats fed on nutraceutical diet exhibits
maximum mean HDL level which non-signiﬁcantly varied in
functional and control group. Similar trend was observed in
study II that HDL increased non-momentously (2.7%) in nu-
traceutical diet group followed by functional (2.5%) groups as
compared to control group. Likewise, in study III a non-
signiﬁcant decrease in HDL level was observed in control
while it elevated in functional and nutraceutical diet i.e. 2.7%
and 3.1%, respectively (Table 3).
3.2.3. LDL
In study I, maximum mean LDL level was observed in
control group that substantially diminished in nutraceutical and
functional diet, respectively (Table 4). A respective decrease of
5.5% and 6.6% was measured in functional and nutraceutical
diet. Similarly, in study II control group exhibited momentously
higher mean LDL level as compared to nutraceutical and func-
tional diet groups. Over the period, maximum decline was
observed in nutraceutical group (12.2%) followed by functional
group (10.1%) in study II. Likewise, in study III, maximumTable 4
LDL (mg/dL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 31.1 ± 1.4 31.3 ± 1.3 31.5 ± 1.0
Functional 30.7 ± 1.4 29.7 ± 1.1 29.0 ± 1.2
Nutraceutical 30.3 ± 1.2 29.2 ± 1.0 28.3 ± 1.3
Study II Control 47.0 ± 2.1 47.9 ± 2.3 48.5 ± 1.8
Functional 46.5 ± 2.2 43.8 ± 2.2 41.8 ± 1.7**
Nutraceutical 45.9 ± 2.3 42.7 ± 2.1 40.3 ± 1.9**
Study III Control 60.8 ± 2.5 64.0 ± 2.0 66.3 ± 2.4*
Functional 61.6 ± 2.4 55.7 ± 2.3 51.7 ± 2.3**
Nutraceutical 61.3 ± 2.3 55.4 ± 2.4 50.8 ± 2.5**
Study I (normal rats), study II (hyperglycaemic rats), study III (hy-
percholesterolemic rats). Asterisks indicate that the differences
(*: P < 0.05; **: P < 0.01) between the means of different diets
(control, functional and nutraceutical) are statistically signiﬁcant as
determined by one-way ANOVA with posthoc Tukey's honestly sig-
niﬁcant difference test.
Table 6
Glucose (mg/dL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 91.2 ± 4.2 92.0 ± 4.3 92.5 ± 4.1
Functional 90.3 ± 3.8 88.1 ± 4.1 86.6 ± 3.9*
Nutraceutical 89.7 ± 3.9 87.1 ± 3.9 85.0 ± 4.7*
Study II Control 137.2 ± 6.1 145.2 ± 6.5 150.5 ± 6.7
Functional 136.7 ± 6.2 128.7 ± 6.2 122.7 ± 6.3**
Nutraceutical 135.5 ± 6.0 126.6 ± 6.1 120.2 ± 6.4***
Study III Control 100.0 ± 4.0 102.5 ± 4.9 104.3 ± 4.7
Functional 99.5 ± 4.1 95.1 ± 4.3 92.1 ± 4.1*
Nutraceutical 99.3 ± 3.9 94.2 ± 4.6 90.3 ± 4.8**
Study I (normal rats), study II (hyperglycaemic rats), study III (hyper-
cholesterolemic rats). Asterisks indicate that the differences (*: P < 0.05;
**: P < 0.01; ***: P < 0.001) between the means of different diets
(control, functional and nutraceutical) are statistically signiﬁcant as
determined by one-way ANOVA with posthoc Tukey's honestly sig-
niﬁcant difference test.
Table 7
Insulin (mU/mL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 8.7 ± 0.3 8.7 ± 0.3 8.8 ± 0.2
Functional 8.3 ± 0.4 8.5 ± 0.3 8.6 ± 0.2
Nutraceutical 8.2 ± 0.6 8.4 ± 0.4 8.5 ± 0.3*
Study II Control 12.3 ± 0.5 12.2 ± 0.5 12.0 ± 0.5
Functional 12.1 ± 0.5 12.5 ± 0.3 12.9 ± 0.3*
Nutraceutical 11.7 ± 0.4 12.3 ± 0.4 12.7 ± 0.4**
Study III Control 10.5 ± 0.4 10.5 ± 0.4 10.4 ± 0.4
Functional 9.9 ± 0.3 10.1 ± 0.4 10.3 ± 0.4
Nutraceutical 9.6 ± 0.3 9.9 ± 0.3 10.2 ± 0.4*
Study I (normal rats), study II (hyperglycaemic rats), study III (hyper-
cholesterolemic rats). Asterisks indicate that the differences
(*: P < 0.05; **: P < 0.01;) between the means of different diets
(control, functional and nutraceutical) are statistically signiﬁcant as
determined by one-way ANOVA with posthoc Tukey's honestly sig-
niﬁcant difference test.
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trailed by functional diet group (16.00%).
3.2.4. Triglycerides
Treatments impart signiﬁcant effects on triglycerides level in
all the three studies; whilst, days interval imparted non-
momentous effect in study I while signiﬁcant effect in case of
study II and III. Mean triglycerides in study I was at highest
level in control followed by functional and nutraceutical groups.
In functional group a reduction of 3.4% was observed, whilst, in
nutraceutical group 4.4% decline in triglycerides level was
noticed from 0 to 60th day. Similarly, in study II, maximum
reduction was observed in nutraceutical group followed by
functional group as 8.2% and 6.6%, respectively. Likewise, in
study III nutraceutical diets showed greater suppression for this
attribute as compared functional and control group. Nutraceuti-
cal diet showed maximum reduction (11.6%) trailed by func-
tional group (10.0%) (Table 5).
3.3. Hypoglycaemic potential of black cumin extracts
3.3.1. Glucose
Mean serum glucose level in study I was maximum in control
group trailed signiﬁcantly by functional and nutraceutical
groups. Functional and nutraceutical diets cause 4.1% and 5.2%
reduction in the level of glucose from 0 to 60th day. Whereas, in
study II nutraceutical group illustrated maximum reduction in
mean glucose level (11.3%) trailed by functional group (10.2%).
Likewise, in high cholesterol fed rats (study III) maximum
alleviation of glucose was noticed in nutraceutical diet group
followed by functional group as 9.1% and 7.4%, correspond-
ingly (Table 6).
3.3.2. Insulin
Insulin level in study I was (8.8 ± 0.2), (8.6 ± 0.2) and
(8.5 ± 0.3) mU/mL in control, functional and nutraceutical diets,
respectively at 60th day. It was observed that in control, func-
tional and nutraceutical groups of normal rats the level of insulin
raised non-signiﬁcantly with time interval. Nonetheless in study
II, maximum increase in insulin level was recorded in nutra-
ceutical group followed by functional diet group as 8.5% and
6.6%, correspondingly. Similarly, in study III, control group
showed a decrease in mean insulin value from (10.5 ± 0.4) toTable 5
Triglycerides (mg/dL) of rats in different studies.
Studies Diet groups 0 d 30 d 60 d
Study I Control 67.4 ± 2.5 67.7 ± 2.1 67.9 ± 2.2
Functional 66.8 ± 2.1 65.4 ± 2.3 64.5 ± 2.3*
Nutraceutical 65.2 ± 2.3 63.5 ± 2.1 62.3 ± 2.4*
Study II Control 77.7 ± 2.8 79.1 ± 2.7 80.1 ± 2.9
Functional 76.3 ± 2.6 73.4 ± 2.5 71.2 ± 2.8*
Nutraceutical 75.4 ± 2.5 71.8 ± 2.3 69.2 ± 2.7*
Study III Control 95.5 ± 4.1 99.9 ± 4.0 103.1 ± 5.0*
Functional 96.7 ± 3.9 90.9 ± 4.1 87.0 ± 4.8**
Nutraceutical 95.9 ± 3.2 89.5 ± 3.9 84.7 ± 4.4**
Study I (normal rats), study II (hyperglycaemic rats), study III (hy-
percholesterolemic rats). Asterisks indicate that the differences
(*: P < 0.05; **: P < 0.01) between the means of different diets
(control, functional and nutraceutical) are statistically signiﬁcant as
determined by one-way ANOVA with posthoc Tukey's honestly sig-
niﬁcant difference test.(10.4 ± 0.4) mU/mL while increasing trend was observed in both
functional (4.0%) and nutraceutical (6.2%) diet groups
(Table 7).
4. Discussion
Globally, nutraceuticals and functional foods are in limelight
owing to their health enhancing characteristics. It has been
noticed that functional foods have established their therapeutic
worth by alleviating numerous lifestyle related disorders like
inﬂammations, hyperglycaemia and hypercholesterolaemia [28].
The present observations agree with the ﬁndings of Meral
et al. [29] and Kanter et al. [30]. They concluded that feed
intake and weight gain were higher in control group as
compared to black cumin enriched treatments. Furthermore, it
was reported that feed intake and weight gain increased with
high-fat diets while supplementation of antioxidants can con-
trol the deposition of fat in the body [31]. Reduction in feed and
drink intakes may be owing to black cumin slight anorexic
effects [31]. Later, Sultan et al. [32] observed that control group
has maximum feed intake while groups fed on diets rich in
black cumin ﬁxed oil showed least intake i.e. (21.26 ± 2.13)
and (20.17 ± 1.22) mg/rat/day, respectively. They also noted
elevated water intake with the passage of study period. It has
also been observed that weight gain of groups fed on black
cumin ﬁxed and essential oils is 13.9% and 11.4% lower than
Muhammad Jawad Iqbal et al./Asian Pac J Trop Biomed 2017; 7(11): 1014–10221020control group. Moreover, Parhizkar et al. [31] observed that
during treatment period, the body weight of control and
supercritical extract fed group of rats was increased at the
initiation of study afterwards it maintained at a certain point.
This inﬂuence of extracts on body weight might be related to
the black cumin action on metabolism of lipid.
In present study the serum cholesterol level of rats decreased
in groups fed on nutraceutical diets as well as functional diets,
whilst, it shows an elevated trend in control group. The ﬁndings
are in accordance with the outcomes of Le et al. [33], which was
reported that ether extracts of black cumin signiﬁcantly reduced
the cholesterol level of rats. Previously, it has also been depicted
that volatile oil of black cumin is very effective against
hyperlipidaemia [34]. Cholesterol lowering property of black
cumin may be owing to reduction in hepatocytic synthesis of
serum cholesterol or by lowering reabsorption in small
intestine [24]. It was conjectured that activation of peroxisome
proliferator-activated receptor is responsible for cholesterol
reducing mechanism [35].
Results regarding the serum LDL level are in accordance
with previous literature as Salem [36] reported the reduction of
non- HDL cholesterol fractions by induction of black cumin
extracts in diet. Afterwards, Buriro and Tayyab [25] elucidated
that low fat diet supplemented with black cumin and 3%
sunﬂower oil cause notable lowering of LDL cholesterol of
blood serum. Likewise, it was reported that 30 mg
administration of black cumin per kg body weight of rats for
20 weeks study interval signiﬁcantly lowered the LDL level of
blood from (35.73 ± 3.56) to (24.35 ± 2.40) mg/dL. Besides,
Sultan et al. [37] expounded that at dose 1% and 2%, black
cumin powder reduced serum low density lipoprotein level
24.7% and 24.3%, respectively. One of their peers, Al-Naqeep
et al. [38] while working on atherosclerosis gave conclusions
that feeding of rabbits by black cumin enriched diet
signiﬁcantly decrements the LDL level of serum. Frequent
changes in the plasma lipid concentration are observed in
diabetic patients that certainly contribute to the development
of vascular diseases. The free radical generation associated
with LDL modiﬁcation can further lead to atherosclerosis [39].
The present ﬁndings agree with the ﬁndings of Kanter et al.
[30]. It was hypothesized the cholesterol deposition was due to
increased activities of cholesterol synthesizing enzyme and
reduced activities of antioxidants. Considering the negative
association of serum cholesterol with tocopherols, it can be
hypothesized that supplementation of diets with rich sources
of tocopherols can reduce the elevated cholesterol level [40].
Recently, it has been reported that supplementation of N.
sativa momentously lowered plasma levels of cholesterol,
LDL and triglycerides to about 15.65, 14.10 and 20.64 mg/dL,
respectively [41].
Current ﬁndings regarding the serum triglyceride level are in
line with the ﬁndings of Le et al. [33], which proved that the N.
sativa signiﬁcantly decreased the triglycerides level of blood as
compared to control group. Likewise, Ko¨kdil et al. [42] gave
orally 1 mL of black cumin ﬁxed oil/kg body weight to the
diabetic rats for 4 weeks and suggested that the triglycerides
levels signiﬁcantly decreased during the research work.
Besides, Murugesan et al. [43] testiﬁed that when the black
cumin was given at 150 mg/kg body weight for 15 d, it
signiﬁcantly declined the triglyceride level of blood that was
(132.02 ± 0.69) mg/dL at the ﬁrst day and (119.06 ± 0.44)
mg/dL at the termination of study.It was observed that the serum HDL level increased non-
signiﬁcantly in all three studies. The ﬁndings are in harmony
with explorations of El-Dakhakhny [44] and they reported an
increase in HDL level by oral feeding of black cumin oil to
rats as compared to control group. According to a report, dose
rate of 30 mg/kg body weight of albino rats signiﬁcantly
increased the level of HDL in serum.
The results obtained regarding the effects of black cumin on
serum glucose level in current research are similar with the
ﬁndings of Mohtashami et al. [45], in which they used volunteer
humans in the research and gave them 2.5 mL of black cumin
ﬁxed oil twice a day for two weeks. At the beginning of the
study the glycaemic index of that group was (102.4 ± 20.8)
mg/dL that was decreased to (91.5 ± 12.5) mg/dL. In that
research, it was noticed that the ﬁxed oil dose of 5 mL per
day has signiﬁcantly reduced the blood glucose level of
people and did not cause any side effect. Similarly, Ko¨kdil
et al. [42] suggested that the blood glucose level momentously
decreased when the rats were supplemented with 1 mL of
black cumin ﬁxed oil per day for four weeks. Meanwhile, in
another exploration a hypothesis was developed that elevated
glucose level in diabetic rats may in turn trigger the enhanced
insulin release in serum due to gluconeogenesis in liver is
altered [46].
Afterwards, Kanter [47] concluded that notable reduction in
glucose and elevation in serum insulin level in diabetic rats
can be observed by an administrating 400 mg/kg/day and
50 mg/kg/day of black cumin powder and thymoquinone,
respectively. Hypoglycaemic activity of black cumin may be
due to stimulation of release of insulin and partial proliferation
of pancreatic beta-cells, mediated by extra pancreatic actions
[30]. Moreover, hyperglycaemia is developed by hepatic
production of glucose diabetic patients which tends to
decrease due to black cumin extract treatments [48]. It has also
been observed that level of various enzymes increased in
serum ultimately reduces the permeability of glucose
precursors to hepatic system and lowering the process of
gluconeogenesis [29]. In case of serum insulin level, the data
obtained from the present research was comparable with the
ﬁndings of Le et al. [33], in which they demonstrated that
petroleum ether extract of black cumin exerted an in vivo
insulin-sensitizing action.
In conclusion, this research investigates that black cumin
conventional as well as supercritical ﬂuid extracts possess sig-
niﬁcant hypoglycaemic and hypocholesterolemic potential.
Furthermore, supercritical ﬂuid extracts are more efﬁcient as
compared to conventional extracts which may be owing to su-
perior recovery of bioactive moieties through supercritical ﬂuid
extraction technique as compared to conventional technique.
The ﬁndings of current investigation would be helpful in
designing various functional foods to curtail the metabolic
dysfunctions like hyperglycaemia and hypercholesterolaemia.
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